Nomad Foods (NYSE: NOMD) grants 1M stock options to co-chair Noam Gottesman
Rhea-AI Filing Summary
Gottesman Noam reported acquisition or exercise transactions in this Form 4 filing.
Nomad Foods director and co-chair Noam Gottesman reported a compensation-related award of stock options. He received 1,000,000 stock options to buy Ordinary Shares at $10.14 per share, expiring on May 7, 2031. The options vest only if he meets co-investment requirements under the Issuer's Co-Investment and Share Option Matching Sub Plan between May 5, 2025 and June 5, 2027, and the company achieves a specified share price performance target during the period from May 7, 2026 to May 7, 2031. Vesting, if it occurs, will be on the later of May 7, 2029 or achievement of that performance target.
Following the reported positions, Gottesman holds 3,871,541 Ordinary Shares directly and 6,708,560 Ordinary Shares indirectly through TOMS Capital Investments LLC. The footnote states he controls, and indirectly owns, 100% of that LLC's interests in these shares and disclaims beneficial ownership to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 1,000,000 | $0.00 | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (1)
- These shares are held indirectly by TOMS Capital Investments LLC, a Delaware limited liability company through a wholly-owned subsidiary. The Reporting Person controls, and indirectly owns, 100% of TOMS Capital Investments LLC's interests in these shares. The Reporting Person disclaims beneficial ownership of such shares to the extent of his pecuniary interest therein. Subject to (i) the Reporting Person satisfying the share purchase component under the Issuer's Co-Investment and Share Option Matching Sub Plan (the "Sub Plan") between May 5, 2025 and June 5, 2027 and (ii) the Issuer's achievement of the share price performance target during the period beginning May 7, 2026 and ending on May 7, 2031 (the "Performance Period"), the Options will vest and become exercisable, if at all, on the later of (x) May 7, 2029 and (y) the achievement of the specified share price performance target during the Performance Period.